Agilent launches miRNA Microarrays featuring miRBase 21 content

Agilent has introduced updates to its SurePrint miRNA Microarrays to include targets from the latest public miRNA miRBase database, miRBase 21.

The newest database contains 28,645 entries, including more than 15 percent in content added from miRBase 20. Incorporating targets from this collection will further enhance the usability of Agilent's SurePrint miRNA Microarray range.

Offering comprehensive coverage, superior data reproducibility and updated user content, the microarrays have been optimised with innovative labeling and hairpin probe designs to provide exceptional sequence and size discrimination.

In a recent benchmark test, they exhibited excellent performance with the highest titration response, reproducibility and precision of all testes options, while requiring the lowest sample amount among the next-closest performing assays.

Alessandro Borsatti, senior director of marketing for Agilent's diagnostics and genomics group, said: "We maintain our commitment to microarrays because they provide well-proven and established workflows for scientists seeking the greatest efficiency and cost-effectiveness for investigating miRNAs."

Earlier this month, the company announced that it will be discontinuing its nuclear magnetic resonance business in order to focus on higher-growth areas.